Insider Selling: Cardinal Health (NYSE:CAH) CEO Sells $6,187,191.50 in Stock

Key Points

• Stephen Mason, CEO of Cardinal Health, sold 41,575 shares of the company's stock for approximately $6.19 million, significantly reducing his ownership by 61.45%.
• Cardinal Health reported $2.08 earnings per share for the last quarter, exceeding analysts' estimates, but reported a slight revenue decline compared to the previous year.
• The company declared a quarterly dividend of $0.5107 per share, set to be paid on October 15th, with a yield of 1.4% and a payout ratio of 31.63%.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) CEO Stephen M. Mason sold 41,575 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Cardinal Health Stock Down 2.3%

Shares of Cardinal Health stock traded down $3.5270 on Friday, hitting $148.0430. The company's stock had a trading volume of 2,685,985 shares, compared to its average volume of 2,600,685. The company has a market capitalization of $35.35 billion, a P/E ratio of 22.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.67. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44. The firm has a fifty day moving average price of $159.02 and a 200-day moving average price of $145.58.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.4%. Cardinal Health's dividend payout ratio is presently 31.63%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CAH. NewEdge Advisors LLC increased its stake in shares of Cardinal Health by 5.3% during the 4th quarter. NewEdge Advisors LLC now owns 12,429 shares of the company's stock valued at $1,470,000 after acquiring an additional 622 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Cardinal Health by 39.9% during the 4th quarter. First Trust Advisors LP now owns 222,764 shares of the company's stock valued at $26,346,000 after acquiring an additional 63,535 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Cardinal Health by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,238,848 shares of the company's stock valued at $146,517,000 after acquiring an additional 15,212 shares during the last quarter. Norinchukin Bank The increased its stake in shares of Cardinal Health by 10.1% during the 4th quarter. Norinchukin Bank The now owns 11,211 shares of the company's stock valued at $1,326,000 after acquiring an additional 1,028 shares during the last quarter. Finally, MetLife Investment Management LLC increased its stake in shares of Cardinal Health by 0.7% during the 4th quarter. MetLife Investment Management LLC now owns 70,454 shares of the company's stock valued at $8,333,000 after acquiring an additional 471 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on CAH shares. Wall Street Zen cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Saturday, August 2nd. Leerink Partners decreased their price objective on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Finally, Bank of America upped their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a report on Tuesday, June 10th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $163.20.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.